For Finextra's free daily newsletter, breaking news and flashes and weekly job board.
You raise an issue that might be impossible to solve completely. OTC by definition are bespoke transactions created to specific requirements of the issuer and their client. This bespoke nature causes non standard componants.
Its very unlikely that the buy side will have the motivation to invest in technology to build any automated solution as the transactions tend to be on a one on one basis. The nature of OTC derivertives causes them to be automatically highlighted against
bog standard vanilla transactions and they are normally subject to far greater scrutiny by managment.
I understand your sentiment to bring automation but feel it is bridge too far, way over the horizon to be seen.
19 Mar 2009
This post is from a series of posts in the group:
A community to discuss the future of financial services and any other interesting trends, strategies, ideas, views.